Varian reports Q2 revenue, profit gains
Article Thumbnail ImageApril 25, 2013 -- Demand for its x-ray products contributed to revenue and earnings growth for radiation therapy firm Varian Medical Systems in its fiscal second quarter.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
MemberID or E-mail Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
using your social networking account:
using your social networking

For the quarter (end-April 1), the vendor had revenues of $768 million, up 7% from the $720 million reported in the second quarter of fiscal 2012. Varian had net earnings of $113 million, compared with $108 million a year ago.

For the six-month period, Varian's revenues were $1.4 billion, up 8% from the $1.3 billion reported in fiscal 2012. Net earnings were $208 million, compared with $198 million for the same period a year ago.

Revenues in the company's Oncology Systems unit were $582 million in the second quarter, up 3% from $565 million in 2012. Oncology Systems revenues were stable during the six-month period as compared to last year. For its X-Ray Products business, Varian posted revenues of $140 million for the second quarter of 2013, up 14% compared to $123 million for the same period last year. The unit's six-month revenues grew 15%, from $236 million in 2012 to $273 million in 2013.